Patient-centered cardiovascular care enhances outcomes

Adult cardiovascular care centered on the patient can improve individuals’ experiences and their medical outcomes, according to a new American Heart Association Scientific Statement published today in Circulation.

CRISPR-Cas13 emerges as a game changer in RNA-targeted therapies

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the development of the CRISPR (Clustered Regularly

September 25, 2024

Rare disease biopharma companies weigh in on FDA’s new innovation hub

AstraZeneca’s Alexion, BridgeBio, BioMarin, Ultragenyx and others, including Sen. Bob Casey (D-PA), recently weighed in on the details of a new cross-cutting FDA collaboration hub

November 5, 2024

Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors

An investigational combination of CTLA-4 and PD‐1 checkpoint inhibitors demonstrated “encouraging” tumor activity, as well as a manageable safety profile, in patients with advanced/metastatic solid

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.